Skip to main content

Table 2 Summary of the CRT boost treatment

From: Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study

Structure

Parameter

All patients Median (Range)

Patient 4 Grade 3 Rectal Bleeding

Patient 10 Grade 3 Rectal Bleeding

Tumor

Dose (Gy)

25.2 (20–30)

20

30

 

PTV (cm3)

151 (58–512)

512

393

 

CN

0.58 (0.34–0.78)

0.74

0.75

Rectum

Volume1 (cm3)

67 (29–147)

61

73

 

Overlap with PTV2 (%)

15 (1–56)

41

46

 

V50 (cm3)

57 (22–128)

60

63

 

V70 (cm3)

45 (16–113)

58

53

Bladder

Volume1 (cm3)

183 (49–555)

148

325

 

Overlap with PTV2 (%)

11 (4–35)

35

20

 

V50% (cm3)

125 (32–187)

148

161

 

V70% (cm3)

79 (23–145)

145

106

  1. (1) Rectal and bladder contoured volume before expansion to form the planning risk volume (PRV)
  2. (2) Percentage of the rectum or bladder volume within the PTV
  3. (V50%)The volume receiving ≥ 50% of the prescribed dose
  4. (V70%) The volume receiving ≥ 70% of the prescribed dose
  5. (PTV) Planning target volume
  6. (CN) Conformation Number.